These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies. Guindi M; Yazdi HM; Gilliatt MA Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832 [TBL] [Abstract][Full Text] [Related]
10. Liver disease in adults with alpha-1 -antitrypsin deficiency. Berg NO; Eriksson S N Engl J Med; 1972 Dec; 287(25):1264-7. PubMed ID: 4117996 [No Abstract] [Full Text] [Related]
11. Atypical presentation of hepatocellular carcinoma. UyBarreta V; Mikesh C; Simmons B; Beech DJ South Med J; 2000 May; 93(5):516-9. PubMed ID: 10832956 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166 [TBL] [Abstract][Full Text] [Related]
13. Morphological features: their usefulness is the diagnosis, prognosis, and management of cirrhosis. Baggenstoss AH Clin Gastroenterol; 1975 May; 4(2):227-46. PubMed ID: 123834 [No Abstract] [Full Text] [Related]
15. Chronic active hepatitis and hepatic failure in the setting of idiopathic hemochromatosis. Stankoski JA; Roth JA; Gillin JS Am J Gastroenterol; 1987 Jan; 82(1):61-5. PubMed ID: 3799582 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma. Altaf FJ Saudi Med J; 2001 May; 22(5):416-8. PubMed ID: 11376383 [TBL] [Abstract][Full Text] [Related]
17. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases. Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic approach to metabolic liver disease: Part 1. Jevon GP; Dimmick JE Pediatr Dev Pathol; 1998; 1(3):179-99. PubMed ID: 10463278 [No Abstract] [Full Text] [Related]
19. [Hepatocellular carcinoma in patients with metabolic liver disease]. Takeuchi Y; Sugimoto M Nihon Rinsho; 2001 Oct; 59 Suppl 6():469-73. PubMed ID: 11761995 [No Abstract] [Full Text] [Related]
20. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Teitelbaum DH; Tuttle S; Carey LC; Clausen KP Ann Surg; 1985 Jul; 202(1):36-41. PubMed ID: 2409935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]